A citation-based method for searching scientific literature

Steven E Nissen, Kathy Wolski. N Engl J Med 2007
Times Cited: 2870

Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull, Christopher P Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, David C Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M Brenner, Kenneth W Mahaffey. N Engl J Med 2019
Times Cited: 1050

List of shared articles

Times cited

SGLT-2 inhibitors may be targeting higher risk patients with diabetes possibly justifying higher cost: Single center repeated cross-sectional analysis.
Larry A Weinrauch, Jiankang Liu, Alissa R Segal, Jason Woodward, John A D'Elia. J Diabetes Complications 2021

Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective.
Jing Cui, Yanfei Liu, Yiwen Li, Fengqin Xu, Yue Liu. Front Cardiovasc Med 2021

Second revolution in cardiovascular prevention.
Chern-En Chiang, Kang-Ling Wang, Hao-Min Cheng, Shih-Hsien Sung, Tze-Fan Chao. J Chin Med Assoc 2020

Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases.
Nikolaus Marx, Lars Rydén, Frank Brosius, Antonio Ceriello, Michael Cheung, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod,[...]. Diabetes Res Clin Pract 2020

Diabetes and coronary artery disease: not just a risk factor.
Peter J Grant, Francesco Cosentino, Nikolaus Marx. Heart 2020

Non-insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials.
Gianluigi Savarese, Benedikt Schrage, Francesco Cosentino, Lars H Lund, Giuseppe M C Rosano, Petar Seferovic, Javed Butler. ESC Heart Fail 2020

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
Ehtasham Ahmad, Jack A Sargeant, Francesco Zaccardi, Kamlesh Khunti, David R Webb, Melanie J Davies. Pharmaceuticals (Basel) 2020

Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?
Ruth L Coleman, Alastair M Gray, Uli C Broedl Md, David Fitchett, Jyothis T George, Hans J Woerle, Bernard Zinman, Rury R Holman. Diabetes Obes Metab 2020

Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.
Tanya Wilcox, Christophe De Block, Arthur Z Schwartzbard, Jonathan D Newman. J Am Coll Cardiol 2020

RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020.
Rajeev Chawla, S V Madhu, B M Makkar, Sujoy Ghosh, Banshi Saboo, Sanjay Kalra. Indian J Endocrinol Metab 2020

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Abhinav Sharma, Neha J Pagidipati, Robert M Califf, Darren K McGuire, Jennifer B Green, Dave Demets, Jyothis Thomas George, Hertzel C Gerstein, Todd Hobbs, Rury R Holman,[...]. Circulation 2020

Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
Tobias Täger, Dan Atar, Stefan Agewall, Hugo A Katus, Morten Grundtvig, John G F Cleland, Andrew L Clark, Hanna Fröhlich, Lutz Frankenstein. Heart Fail Rev 2020

2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
Chern-En Chiang, Kwo-Chang Ueng, Ting-Hsing Chao, Tsung-Hsien Lin, Yih-Jer Wu, Kang-Ling Wang, Shih-Hsien Sung, Hung-I Yeh, Yi-Heng Li, Ping-Yen Liu,[...]. J Chin Med Assoc 2020

Insulin: Trigger and Target of Renal Functions.
Ana F Pina, Diego O Borges, Maria João Meneses, Patrícia Branco, Rita Birne, Antonio Vilasi, Maria Paula Macedo. Front Cell Dev Biol 2020